Vitiligo Treatment Market to cross double digit growth rate by 2031

Vitiligo, known as piebald skin or leukoderma, is a dermatology disorder caused due to deficiency of melanin pigment and characterized by development of white spots on the skin. This condition tends to advance over the time, with larger depigmentation spots on the skin, however in some individuals, patches can remain stable. It is an autoimmune physical disorder, sometimes transmitted genetically from parent to offspring.

The symptoms of vitiligo are patchy loss of skin color, whitening of the hair present on scalp, and loss of color from mucous membrane. Furthermore, people with vitiligo are more susceptible to get other autoimmune diseases such as Addison's disease and hypothyroidism. The long-term effects of vitiligo are mental stress, skin cancer, iritis, and hearing loss due to loss of cochlear melanocytes.

Request Sample of Report- https://www.alliedmarketresearch.com/request-sample/31914

The global vitiligo treatment market was estimated at $410.5 million in 2021 and is expected to hit $625.8 million by 2031, registering a CAGR of 4.3% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

By drug class type, the corticosteroids segment garnered more than two-thirds of the global vitiligo treatment market in 2021, and would rule the roost by the end of 2031. The same segment would also display the fastest CAGR of 4.7% from 2022 to 2031. The calcineurin inhibitor segment is also assessed in the study.

Based on region, the global vitiligo treatment market across North America generated nearly two-fifths of the total market revenue in 2021, and is anticipated to retain the lion's share by 2031. The Asia-Pacific region, simultaneously, would showcase the fastest CAGR of 5.4% throughout the forecast period. The other provinces analyzed through the report include Europe and LAMEA.

Speak to Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/31914

Depending on drug class type, the vitiligo treatment industry is fragmented into corticosteroids, calcineurin inhibitor, and others. The corticosteroid segment was the major revenue contributor in 2021, and expected to exhibit fastest growth during the forecast period, owing to rise in demand for corticosteroids as it shows significant result in non-segmental vitiligo treatment.

The key market players analyzed in the global vitiligo treatment market report include Astellas Pharma Inc., Bristol-Mayers Squibb (Celegen), Bausch Health Companies Inc. (Bausch+Lomb Inc.), Dermavant Science Inc., Dr. Reddy's Laboratories Ltd, Incyte Corporation, Merck kGaA, Arcutis Biotherapeutics, Pfizer Inc., and Viatirs Inc. (Mylan N.V.).

Read More- https://www.alliedmarketresearch.com/vitiligo-treatment-market-A31464

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.